<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23198" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Hyperosmolar Hyperglycemic Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adeyinka</surname>
            <given-names>Adebayo</given-names>
          </name>
          <aff>The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kondamudi</surname>
            <given-names>Noah P.</given-names>
          </name>
          <aff>Icahn School of Medicine at Mount Sinai , The Brooklyn Hospital Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adebayo Adeyinka declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noah Kondamudi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23198.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Hyperosmolar hyperglycemic syndrome (HHS) is a clinical condition that arises from a complication of diabetes mellitus. Type 2 diabetes accounts for about 90% to 95% of diabetes cases. It is most commonly seen in patients with obesity. As a consequence of obesity and high body mass index (BMI), there is the resistance of the peripheral tissue to the action of insulin. The beta-cell in the pancreas continues to produce insulin, but the amount is not enough to counter the effect of the resistance of the end organ to its effect. HHS is a serious and potentially fatal complication of type 2 diabetes. The mortality rate in HHS can be as high as 20% which is about 10 times higher than the mortality seen in diabetic ketoacidosis. This activity reviews the pathophysiology of hyperosmolar hyperglycemic nonketotic syndrome and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the difference between diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic syndrome.</p></list-item><list-item><p>Outline the prevalence of hyperosmolar hyperglycemic nonketotic syndrome in type 2 diabetes.</p></list-item><list-item><p>Describe the evaluation of hyperosmolar hyperglycemic nonketotic syndrome.</p></list-item><list-item><p>Summarize the role of the interprofessional team in the management of hyperosmolar hyperglycemic nonketotic syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23198&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23198">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23198.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Hyperosmolar hyperglycemic syndrome (HHS) is a clinical condition that arises from a complication of diabetes mellitus. This problem is most commonly seen in type 2 diabetes. Won Frerichs and Dreschfeld first described the disorder around 1880. They described patients with diabetes mellitus with profound hyperglycemia and glycosuria without the classic Kussmaul breathing or acetone in the urine seen in diabetic ketoacidosis. This clinical condition was formerly called non-ketotic hyperglycemic coma, hyperosmolar hyperglycemic non-ketotic syndrome, and hyperosmolar non-ketotic coma (HONK).<xref ref-type="bibr" rid="article-23198.r1">[1]</xref></p>
        <p>Diabetes mellitus is a clinical condition associated with hyperglycemia as the main metabolic disorder.<xref ref-type="bibr" rid="article-23198.r2">[2]</xref>&#x000a0;This is a result of an absolute or relative deficiency of insulin. Insulin is an anabolic hormone produced by the beta cells of the islets of Langerhans in the pancreas. The main function of this hormone is to lower the level of glucose in the blood by promoting the uptake of glucose by the adipose tissue and skeletal muscle, known as glycogenesis. Insulin also inhibits the breakdown of fat in the adipose tissue,&#x000a0;known as lipolysis. The metabolic effect of insulin is countered by hormones such as glucagon and catecholamines.<xref ref-type="bibr" rid="article-23198.r3">[3]</xref></p>
        <p>In type 1 diabetes, there is the autoimmune destruction of the beta cells in the pancreas. Only about 5% to 10% of all diabetes falls into this category. The most common complication of type 1 diabetes is diabetic&#x000a0;ketoacidosis (DKA).</p>
        <p>Type 2 diabetes accounts for about 90% to 95% of diabetes cases.<xref ref-type="bibr" rid="article-23198.r4">[4]</xref>&#x000a0;It is most commonly seen in patients with obesity. As a consequence of obesity and high body mass index (BMI), there is resistance of the peripheral tissue to the action of insulin. The beta-cell in the pancreas continues to produce insulin, but the amount is not enough to counter the effect of the resistance of the end organ to its effect.</p>
        <p>HHS is a serious and potentially fatal complication of type 2 diabetes.</p>
        <p>The mortality rate in HHS can be as high as 20%, which is about 10 times higher than the mortality seen in diabetic&#x000a0;ketoacidosis.<xref ref-type="bibr" rid="article-23198.r5">[5]</xref><xref ref-type="bibr" rid="article-23198.r6">[6]</xref> Clinical outcome and prognosis in HHS are determined by several factors: age, the degree of dehydration,&#x000a0;and the presence or lack of other comorbidities.<xref ref-type="bibr" rid="article-23198.r7">[7]</xref><xref ref-type="bibr" rid="article-23198.r8">[8]</xref><xref ref-type="bibr" rid="article-23198.r9">[9]</xref></p>
      </sec>
      <sec id="article-23198.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>In children and young adults with type 1 and type 2 diabetes, infectious diseases and disorders of the respiratory, circulatory, and genitourinary systems can cause HHS. Obesity and incessant consumption of carbohydrate-rich beverages have led to an increase in the incidence of HHS.<xref ref-type="bibr" rid="article-23198.r10">[10]</xref><xref ref-type="bibr" rid="article-23198.r11">[11]</xref></p>
        <p>This is particularly true in the pediatric population, where the incidence of type 2 diabetes is on the rise.</p>
        <p>As stated earlier, HHS is most commonly seen in patients with type 2 diabetes. If diabetes mellitus is well controlled, the chance of developing HHS is minimal. However, under certain conditions, some factors might initiate the development of HHS. The most frequent reason for this complication is infection. The infectious process in the respiratory, gastrointestinal, and genitourinary systems can act as the causative factor. The reason for this is the insensible water loss and the release of endogenous catecholamines. Approximately 50% to 60% of HHS is attributable to an infectious etiology.<xref ref-type="bibr" rid="article-23198.r11">[11]</xref><xref ref-type="bibr" rid="article-23198.r12">[12]</xref><xref ref-type="bibr" rid="article-23198.r13">[13]</xref></p>
        <p>Some medications for the treatment of other ailments and conditions in elderly patients with type 2 diabetes can trigger HHS. Examples of such medications are thiazide diuretics, beta-blockers, glucocorticoids, and some atypical antipsychotics.<xref ref-type="bibr" rid="article-23198.r14">[14]</xref><xref ref-type="bibr" rid="article-23198.r15">[15]</xref></p>
        <p>A cardiovascular insult like stroke, angina pectoris, and myocardial infarction can also trigger a stress response. This leads to the release of counterregulatory hormones with the resultant effect of an increased level of blood glucose, causing osmotic diuresis and dehydration, with the final result being HHS.</p>
      </sec>
      <sec id="article-23198.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>There is insufficient data on the epidemiology of HHS. Based on some studies, close to 1% of all hospital admission for diabetes is related to HHS.<xref ref-type="bibr" rid="article-23198.r16">[16]</xref><xref ref-type="bibr" rid="article-23198.r17">[17]</xref></p>
        <p>Most cases of HHS are seen in patients in the fifth and sixth decades of life. Typically DKA is more common in the younger population, with the peak age around the fourth decade of life.<xref ref-type="bibr" rid="article-23198.r17">[17]</xref><xref ref-type="bibr" rid="article-23198.r18">[18]</xref></p>
        <p>In the United States, because of the increase in childhood obesity which is related to the consumption of high amounts of carbohydrate-rich diet, there is a significant increase in the incidence of type 2 diabetes. This may lead to an increased incidence of HHS in the pediatric population.</p>
        <p>There is a disproportionally high number of African Americans, Native Americans, and Hispanics who are afflicted with HHS. This might be related to a high prevalence of type 2 diabetes in these particular population groups. HHS can be fatal in morbidly obese African American males.</p>
      </sec>
      <sec id="article-23198.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>HHS has similar pathophysiology to DKA but with some mild dissimilarities. The hallmark of both conditions is the deficiency of insulin. As a consequence of deficiency of this key hormone, there is a decrease in glucose utilization by the peripheral tissue causing hyperglycemia.<xref ref-type="bibr" rid="article-23198.r19">[19]</xref>&#x000a0;The peripheral tissues enter a state of &#x0201c;starvation.&#x0201d;The release of counterregulatory hormones like glucagon, growth hormone, cortisol, and catecholamines stimulates gluconeogenesis and glycogenolysis.<xref ref-type="bibr" rid="article-23198.r19">[19]</xref><xref ref-type="bibr" rid="article-23198.r20">[20]</xref>&#x000a0;This creates a system of vicious cycle where there is an increased level of glucose in the serum but decreased uptake by the peripheral tissues for tissue metabolism. The serum osmolality is determined by the formula 2Na + Glucose /18 + BUN / 2.8. The resultant hyperglycemia increases the serum osmolarity to a significant degree. The glucose level in HHS is usually above 600 mg/dL. Hyperglycemia also creates an increase in the osmotic gradient, with free water drawn out of the extravascular space due to the increased osmotic gradient. Free water with electrolytes and glucose is lost via urinary excretion producing glycosuria, causing moderate to severe dehydration. Dehydration is usually more severe in HHS as compared to DKA, and there is more risk for cardiovascular collapse.<xref ref-type="bibr" rid="article-23198.r21">[21]</xref><xref ref-type="bibr" rid="article-23198.r22">[22]</xref><xref ref-type="bibr" rid="article-23198.r23">[23]</xref><xref ref-type="bibr" rid="article-23198.r24">[24]</xref></p>
        <p>Compared to DKA, the production of ketone bodies is scant in HHS. As a result of the deficiency of insulin, there is increased lipolysis that causes an increased release of fatty acid as an alternative energy substrate for the peripheral tissues. Beta oxidation of fatty acids produces ketone bodies: acetone, acetoacetate, and beta oxybutyric acid. Accumulation of these substrates produces ketonemia and acidemia. Acidemia from ketone bodies stimulates the kidney to retain bicarbonate ions to neutralize the hydrogen ions. This accounts for the low serum bicarbonate level in DKA.</p>
        <p>In HHS, however, because insulin is still being produced by the beta cells in the pancreas, the generation of ketone bodies is minimal. Insulin inhibits ketogenesis. That aside, in HHS, there is a higher level of insulin with an associated lower level of glucagon. Therefore, ketonemia and acidemia, if they happen, they are very mild in HHS.<xref ref-type="bibr" rid="article-23198.r20">[20]</xref><xref ref-type="bibr" rid="article-23198.r25">[25]</xref><xref ref-type="bibr" rid="article-23198.r26">[26]</xref></p>
        <p>The effect of the increased serum osmolarity on the brain can be very profound. To preserve the intracellular volume, the brain produces idiogenic osmoles. Idiogenic osmoles are substances that are osmotically active. The net effect of the production of these substances is to prevent fluid from moving from the intracellular space into the extracellular space and maintain a balanced equilibrium.<xref ref-type="bibr" rid="article-23198.r24">[24]</xref></p>
        <p>The risk of developing cerebral edema is mostly related to how fast the serum osmolarity is decreasing. If the decline is too rapid and the brain is not able to eliminate idiogenic osmoles at the same rate as the decline in serum osmolarity, then the chances of fluid moving into the brain cell and causing swelling are higher. Hence, in the treatment of HHS, the goal of treatment is a slow correction of hyperglycemia.</p>
      </sec>
      <sec id="article-23198.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The history and physical examination are very important in the diagnosis of HHS. In many instances, there is a significant overlap in the signs and symptoms seen in HHS and DKA. In the history taking and&#x000a0;the initial assessment, particular attention should be focused on the insulin regimen, missed dosages of oral hypoglycemic agents, overconsumption of carbohydrate-rich diet, or simultaneous use of medications that can trigger hyperglycemia or cause dehydration.</p>
        <p>If an infectious process precedes HHS, signs and symptoms include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Malaise</p>
          </list-item>
          <list-item>
            <p>General weakness</p>
          </list-item>
          <list-item>
            <p>Tachypnea</p>
          </list-item>
          <list-item>
            <p>Tachycardia</p>
          </list-item>
        </list>
        <p>If the precipitating factor is a cardiac or vascular condition, signs and symptoms will include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Chest pain</p>
          </list-item>
          <list-item>
            <p>Chest tightness</p>
          </list-item>
          <list-item>
            <p>Headache</p>
          </list-item>
          <list-item>
            <p>Dizziness</p>
          </list-item>
          <list-item>
            <p>Palpitations</p>
          </list-item>
        </list>
        <p>The typical clinical presentation of patients with HHS is increased urination (polyuria) and increased water intake (polydipsia). This is a result of the stimulation of the thirst center in the brain from severe dehydration and increased serum osmolarity. Weakness, malaise, and lethargy can also be part of the complaints.</p>
        <p>Severe dehydration from HHS can also affect the skin and integumentary system. Typically, the skin and the oral mucosa are dry with a delayed capillary refill.</p>
        <p>The most important distinguishing factor in HHS is the presence of neurological signs. Decreased cerebral blood flow from severe dehydration can cause:</p>
        <list list-type="bullet">
          <list-item>
            <p>Focal neurological deficit</p>
          </list-item>
          <list-item>
            <p>Disturbance in visual acuity</p>
          </list-item>
          <list-item>
            <p>Delirium</p>
          </list-item>
          <list-item>
            <p>Coma</p>
          </list-item>
        </list>
        <p>A system-based approach is necessary for the physical assessment:</p>
        <list list-type="bullet">
          <list-item>
            <p>General appearance: Patients with HHS are generally ill-appearing with altered mental status</p>
          </list-item>
          <list-item>
            <p>Cardiovascular: Tachycardia, orthostatic hypotension, weak and thready pulse</p>
          </list-item>
          <list-item>
            <p>Respiratory: Rate can be normal, but tachypnea might be present if acidosis is profound</p>
          </list-item>
          <list-item>
            <p>Skin: Delayed capillary refill, poor skin turgor, and skin tenting might not be present even in severe dehydration because of obesity</p>
          </list-item>
          <list-item>
            <p>Genitourinary: Decreased urine output</p>
          </list-item>
          <list-item>
            <p>Central Nervous System (CNS): Focal neurological deficit, lethargy with low Glasgow coma score, and in severe cases of HHS, the patient might be comatose.</p>
          </list-item>
        </list>
        <p>The physical examination should also focus on other comorbidities associated with diabetes mellitus. Acanthosis nigricans, oral thrush, vulvovaginitis, and multiple pustular skin lesions might all indicate poor glycemic control. This is particularly important if HHS is the initial presentation of type 2 diabetes.</p>
      </sec>
      <sec id="article-23198.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnostic criteria for HHS were developed as a result of cases series reported by Gerich et al. Arieff and Carroll also contributed to this work in a separate study, both of which were published in 1971.<xref ref-type="bibr" rid="article-23198.r27">[27]</xref></p>
        <p>According to the recommendation of the American Diabetic Association and current international guidelines, HHS is defined by plasma glucose level greater than 600 mg/dL, plasma effective osmolarity greater than 320 mOsm/L, and absence of significant ketoacidosis.<xref ref-type="bibr" rid="article-23198.r28">[28]</xref></p>
        <p>Hyperosmolar hyperglycemic non-ketotic&#x000a0;coma is no longer accepted as a diagnostic nomenclature because not all patients with HHS will present with coma, even in the presence of significant hyperglycemia and hyperosmolarity.</p>
        <p>The evaluation of HHS requires a detailed history and physical examination. The onset of symptoms and the precipitating factors are very important to elicit from patients. That apart, ancillary studies are also necessary as part of the diagnostic workup.</p>
        <p>The first test in HHS is a fingerstick to determine the serum glucose level. The value is usually between 600 to 1200 mg/dl. The higher the level of glucose, the greater the serum osmolarity and the higher the degree of dehydration.</p>
        <p>
<bold>Glucose</bold>
</p>
        <p>The glucose level should be monitored hourly to guard against a sudden and precipitous drop during treatment with isotonic fluid and insulin. This is to prevent the development of cerebral edema, which is the most dreaded complication in both DKA and HHS. The risk of cerebral edema is higher in HHS.</p>
        <p>
<bold>Hemoglobin A1C</bold>
</p>
        <p>This is a measure of long-term glycemic control and is a useful tool in the assessment of new-onset diabetes mellitus.</p>
        <p>
<bold>Serum Osmolarity</bold>
</p>
        <p>The serum osmolality is very high in HHS. Levels between 320 to 400mOsm/kg are very common in HHS. Normal serum osmolarity is around 280 -290 mOsm/kg. Higher serum osmolarity is associated with alteration in the level of consciousness and might eventually lead to a coma.</p>
        <p>The comprehensive metabolic panel allows for the determination of electrolyte derangements seen in HHS.</p>
        <p>
<bold>Sodium</bold>
</p>
        <p>The sodium level is falsely low (pseudohyponatremia). The hyperglycemic state creates an osmotic gradient, drawing water from the intracellular space into the extracellular space. The correct or true sodium level is usually calculated using the formula:</p>
        <p>Corrected Sodium = Measured sodium + (((Serum glucose - 100)/100) x 1.6)</p>
        <p>
<bold>Potassium</bold>
</p>
        <p>The level of potassium might be high or low. A low level of insulin can cause an extracellular shift of potassium. However, because of ongoing urinary losses, the total body potassium is low in both HHS and DKA. Care must be taken to avoid aggressive correction of hypokalemia in HHS because of decreased glomerular filtration rate from dehydration.</p>
        <p>
<bold>Bicarbonate</bold>
</p>
        <p>Bicarbonate level is usually close to normal in HHS, around 22 to 32 mmol/L, because the production of ketone bodies is minimal as compared to DKA, where the bicarbonate level is usually very low. The anion gap in HHS is normal or close to normal. On the contrary, the anion gap is usually above 12 mmol/L in DKA. The anion gap is determined by the formula:</p>
        <p>(Na +K) - (Cl +HC0)</p>
        <p>If the anion gap is high in HHS, it is usually because of the production of lactic acid from tissue hypoperfusion and decreased circulation.</p>
        <p>
<bold>Magnesium</bold>
</p>
        <p>The magnesium level might be low in HHS.</p>
        <p>
<bold>Phosphorus</bold>
</p>
        <p>Hyperphosphatemia is common in HHS, especially if rhabdomyolysis is a complication. This is a result of muscular tissue breakdown. Administration of insulin and hydration with fluid might lower the phosphorus level as it is driven back into cells. Some of the phosphorus also get excreted by the kidneys as end-organ perfusion improves.</p>
        <p>
<bold>Ketones</bold>
</p>
        <p>Ketonemia is very minimal in HHS. Electrolytes should be monitored serially every 2 to 3 hours in the management of HHS.</p>
        <p>
<bold>Arterial Blood Gases</bold>
</p>
        <p>The role of blood gas is to determine the level of acidosis. In HHS, pH is usually above or around 7.30. The pC0 might be low from hyperventilation. In DKA, serum pH is usually much lower ranging from 6.8 to around 7.2 on initial presentation. Acidosis in HHS is mainly a result of dehydration and compromised end-organ perfusion.</p>
        <p>Arterial blood gases should be monitored every 2 to 3 hours in HHS.</p>
        <p>
<bold>Renal Function</bold>
</p>
        <p>The BUN and creatine levels are usually elevated, reflecting prerenal azotemia. As hydration and insulin therapy are initiated, these values will usually drop and eventually normalize.</p>
        <p>
<bold>Serum Enzymes</bold>
</p>
        <p>The level of serum enzymes like creatinine kinase, aldolase, and transaminases is usually high from hemoconcentration and dehydration.</p>
        <p>
<bold>Complete Blood Count</bold>
</p>
        <p>The white blood cell count might be high because of the stress response or as a result of an infectious process triggering HHS. In most cases, hemoglobin and hematocrit levels are elevated. If the white count is elevated, blood culture, urine culture, and a chest X-ray might be needed to find the source of infection.</p>
        <p>
<bold>Urine Analysis</bold>
</p>
        <p>Urine-specific gravity is high in HHS. Glycosuria and ketonuria are also present.</p>
      </sec>
      <sec id="article-23198.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of HHS requires a multidisciplinary approach. Consultations with an endocrinologist and an intensive care specialist are recommended. Appropriate resuscitation with attention to the principle of Airway, Breathing, Circulation (ABC) should be initiated. Patients with HHS can present with altered mental status as a result of significant fluid depletion and decreased cerebral perfusion. A good rule of thumb is to secure the airway if the Glasgow coma score is less than 8.</p>
        <p>Aggressive hydration with isotonic fluid with electrolyte replacement is the standard practice in the management of HHS. An initial fluid bolus of 15 to 20 ml/kg followed by an infusion rate of 200 to 250 ml/hour are the recommended rates for adults. In pediatric patients, the infusion should run at about twice the maintenance rate. Hydration with isotonic fluid has been shown to help in reducing the amount of counterregulatory hormones produced during HHS. The use of this alone can reduce serum glucose by about 75 to 100 mg/hour. The serum potassium in HHS is usually high, but the total body potassium is low as a result of the extracellular shift from lack of insulin. Potassium replacement should be started when the serum potassium is between 4 to 4.5 mmol/L.<xref ref-type="bibr" rid="article-23198.r29">[29]</xref></p>
        <p>Care should be taken to avoid starting insulin drip in the initial stage of treatment as this might cause a rapid drop in serum glucose levels leading to cerebral edema. It is recommended to try to keep the glucose level around 300 mg/dL to prevent the development of cerebral edema.</p>
        <p>In pediatrics, rehydration and electrolyte correction over a longer period of 48 hours may help in the prevention of cerebral edema.<xref ref-type="bibr" rid="article-23198.r29">[29]</xref><xref ref-type="bibr" rid="article-23198.r30">[30]</xref></p>
      </sec>
      <sec id="article-23198.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis in HHS is divided into 2 broad groups: clinical conditions causing altered mental status and clinical&#x000a0;conditions&#x000a0;causing hyperglycemia.</p>
        <p>The following are some examples of conditions that can cause an alteration in mental status:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Hyponatremia</p>
          </list-item>
          <list-item>
            <p>Hypernatremia</p>
          </list-item>
          <list-item>
            <p>Hyperammonemia</p>
          </list-item>
          <list-item>
            <p>Severe intoxication with drugs or alcohol</p>
          </list-item>
          <list-item>
            <p>Uremic encephalopathy</p>
          </list-item>
        </list>
        <p>Hyperglycemia can develop with diabetic ketoacidosis and diabetes insipidus.</p>
        <p>A detailed history, thorough physical examination, and use of ancillary studies can help to establish a diagnosis quickly.<xref ref-type="bibr" rid="article-23198.r23">[23]</xref></p>
        <p>HHS is a potentially fatal medical condition. Knowledge of pathophysiology and clinical presentation is necessary for the best management outcome.</p>
      </sec>
      <sec id="article-23198.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In general, the overall mortality is low, and it is usually due to the underlying illness that caused the hyperglycemic crisis. Elderly patients who present with severe coma and hypotension have a poorer prognosis compared to younger cohorts.</p>
      </sec>
      <sec id="article-23198.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Electrolytic abnormalities as a consequence of the treatment of HHS are quite frequent. Care needs to be taken to ensure frequent monitoring and avoid adverse side effects. Common electrolytic disturbances include hypokalemia and hypoglycemia.&#x000a0;</p>
        <p>Cerebral edema is a feared but rare complication in HHS. This is more common in the pediatric population and occurs due to the rapid lowering of glucose levels.</p>
      </sec>
      <sec id="article-23198.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Diabetic education including instructions on adequate hydration is essential to avoid recurrent episodes.&#x000a0;</p>
      </sec>
      <sec id="article-23198.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Hyperosmolar Hyperglycemic Nonketotic Coma is a serious complication of type 2 diabetes. Most patients will end up being admitted to the intensive care unit. To improve patient outcomes, an interprofessional approach with good care communication and coordination between the intensivist, nurse, dietician, and endocrinologist is necessary.&#x000a0;</p>
      </sec>
      <sec id="article-23198.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23198&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23198">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/diabetes/hyperosmolar-hyperglycemic-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23198">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23198/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23198">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23198.s15">
        <title>References</title>
        <ref id="article-23198.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pasquel</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
            </person-group>
            <article-title>Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment.</article-title>
            <source>Diabetes Care</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>37</volume>
            <issue>11</issue>
            <fpage>3124</fpage>
            <page-range>3124-31</page-range>
            <pub-id pub-id-type="pmid">25342831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <collab>American Diabetes Association</collab>
            <article-title>Diagnosis and classification of diabetes mellitus.</article-title>
            <source>Diabetes Care</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>33 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>S62</fpage>
            <page-range>S62-9</page-range>
            <pub-id pub-id-type="pmid">20042775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>R&#x000f6;der</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic regulation of glucose homeostasis.</article-title>
            <source>Exp Mol Med</source>
            <year>2016</year>
            <month>Mar</month>
            <day>11</day>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>e219</fpage>
            <pub-id pub-id-type="pmid">26964835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <article-title>Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.</article-title>
            <source>Diabetes Care</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>20</volume>
            <issue>7</issue>
            <fpage>1183</fpage>
            <page-range>1183-97</page-range>
            <pub-id pub-id-type="pmid">9203460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milionis</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Elisaf</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic management of hyperglycaemic hyperosmolar syndrome.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>6</volume>
            <issue>11</issue>
            <fpage>1841</fpage>
            <page-range>1841-9</page-range>
            <pub-id pub-id-type="pmid">16144505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitabchi</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Miles</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemic crises in adult patients with diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>32</volume>
            <issue>7</issue>
            <fpage>1335</fpage>
            <page-range>1335-43</page-range>
            <pub-id pub-id-type="pmid">19564476</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wachtel</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Silliman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lamberton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Predisposing factors for the diabetic hyperosmolar state.</article-title>
            <source>Arch Intern Med</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>148</volume>
            <issue>3</issue>
            <fpage>747</fpage>
            <pub-id pub-id-type="pmid">3341875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wachtel</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Silliman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lamberton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors in the diabetic hyperosmolar state.</article-title>
            <source>J Am Geriatr Soc</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>8</issue>
            <fpage>737</fpage>
            <page-range>737-41</page-range>
            <pub-id pub-id-type="pmid">3611564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wachtel</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Silliman</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lamberton</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Predisposing factors for the diabetic hyperosmolar state.</article-title>
            <source>Arch Intern Med</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>147</volume>
            <issue>3</issue>
            <fpage>499</fpage>
            <page-range>499-501</page-range>
            <pub-id pub-id-type="pmid">3827427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonnell</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pedreira</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Vadamalayan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Werther</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Diabetic ketoacidosis, hyperosmolarity and hypernatremia: are high-carbohydrate drinks worsening initial presentation?</article-title>
            <source>Pediatr Diabetes</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-4</page-range>
            <pub-id pub-id-type="pmid">15963036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitabchi</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Wall</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Diabetic ketoacidosis.</article-title>
            <source>Med Clin North Am</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-37</page-range>
            <pub-id pub-id-type="pmid">7808097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wachtel</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Tetu-Mouradjian</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island.</article-title>
            <source>J Gen Intern Med</source>
            <year>1991</year>
            <season>Nov-Dec</season>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>495</fpage>
            <page-range>495-502</page-range>
            <pub-id pub-id-type="pmid">1765864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wachtel</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>The diabetic hyperosmolar state.</article-title>
            <source>Clin Geriatr Med</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>797</fpage>
            <page-range>797-806</page-range>
            <pub-id pub-id-type="pmid">2224747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hammond</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>New-onset diabetes and ketoacidosis with atypical antipsychotics.</article-title>
            <source>Schizophr Res</source>
            <year>2003</year>
            <month>Jan</month>
            <day>01</day>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-6</page-range>
            <pub-id pub-id-type="pmid">12413635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ananth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Parameswaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gunatilake</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Side effects of atypical antipsychotic drugs.</article-title>
            <source>Curr Pharm Des</source>
            <year>2004</year>
            <volume>10</volume>
            <issue>18</issue>
            <fpage>2219</fpage>
            <page-range>2219-29</page-range>
            <pub-id pub-id-type="pmid">15281897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bradford</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Crider</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Naqvi</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Predictors of Recurrent Hospital Admission for Patients Presenting With Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.</article-title>
            <source>J Clin Med Res</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-39</page-range>
            <pub-id pub-id-type="pmid">27924173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trence</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>IB</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemic crises in diabetes mellitus type 2.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2001</year>
            <month>Dec</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>817</fpage>
            <page-range>817-31</page-range>
            <pub-id pub-id-type="pmid">11727401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacIsaac</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>McNeil</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Tsalamandris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jerums</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies.</article-title>
            <source>Intern Med J</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>379</fpage>
            <page-range>379-85</page-range>
            <pub-id pub-id-type="pmid">12162394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macaulay</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Hyperosmolar non-ketotic diabetes.</article-title>
            <source>Postgrad Med J</source>
            <year>1971</year>
            <month>Apr</month>
            <volume>47</volume>
            <issue>546</issue>
            <fpage>191</fpage>
            <page-range>191-6</page-range>
            <pub-id pub-id-type="pmid">5576486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitabchi</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Kreisberg</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Malone</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Wall</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Management of hyperglycemic crises in patients with diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>131</fpage>
            <page-range>131-53</page-range>
            <pub-id pub-id-type="pmid">11194218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kitabchi</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Nyenwe</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemic crises in diabetes mellitus: diabetic ketoacidosis and hyperglycemic hyperosmolar state.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>725</fpage>
            <page-range>725-51, viii</page-range>
            <pub-id pub-id-type="pmid">17127143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delaney</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Zisman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kettyle</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2000</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>683</fpage>
            <page-range>683-705, V</page-range>
            <pub-id pub-id-type="pmid">11149157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nugent</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Hyperosmolar hyperglycemic state.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>629</fpage>
            <page-range>629-48, vii</page-range>
            <pub-id pub-id-type="pmid">15982538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenbloom</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycemic crises and their complications in children.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-18</page-range>
            <pub-id pub-id-type="pmid">17315523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gordon</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Kabadi</surname>
                <given-names>UM</given-names>
              </name>
            </person-group>
            <article-title>The hyperglycemic hyperosmolar syndrome.</article-title>
            <source>Am J Med Sci</source>
            <year>1976</year>
            <season>May-Jun</season>
            <volume>271</volume>
            <issue>3</issue>
            <fpage>252</fpage>
            <page-range>252-68</page-range>
            <pub-id pub-id-type="pmid">779472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conley</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Hypernatremia.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>1990</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>365</fpage>
            <page-range>365-72</page-range>
            <pub-id pub-id-type="pmid">2184402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arieff</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Hyperosmolar nonketotic coma with hyperglycemia: abnormalities of lipid and carbohydrate metabolism.</article-title>
            <source>Metabolism</source>
            <year>1971</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>529</fpage>
            <page-range>529-38</page-range>
            <pub-id pub-id-type="pmid">4996168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeitler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Haqq</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenbloom</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Glaser</surname>
                <given-names>N</given-names>
              </name>
              <collab>Drugs and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society</collab>
            </person-group>
            <article-title>Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment.</article-title>
            <source>J Pediatr</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>158</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-14, 14.e1-2</page-range>
            <pub-id pub-id-type="pmid">21035820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hockaday</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Alberti</surname>
                <given-names>KG</given-names>
              </name>
            </person-group>
            <article-title>Diabetic coma.</article-title>
            <source>Clin Endocrinol Metab</source>
            <year>1972</year>
            <month>Nov</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>751</fpage>
            <page-range>751-88</page-range>
            <pub-id pub-id-type="pmid">4204136</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23198.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arieff</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Kleeman</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Studies on mechanisms of cerebral edema in diabetic comas. Effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits.</article-title>
            <source>J Clin Invest</source>
            <year>1973</year>
            <month>Mar</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>571</fpage>
            <page-range>571-83</page-range>
            <pub-id pub-id-type="pmid">4685082</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
